These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36518452)

  • 1. Modulation of p-glycoprotein-mediated efflux pirarubicin in living multidrug-resistant K562/Dox cell lines by 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid via impairment of the cellular energetic state.
    Myint O; Wattanapongpitak S; Kothan S; Udomtanakunchai C; Tima S; Tungjai M
    Toxicol Rep; 2022; 9():1443-1451. PubMed ID: 36518452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein binding of 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid to human serum albumin and their anti-proliferation on doxorubicin-sensitive and doxorubicin-resistant leukemia cells.
    Myint O; Wattanapongpitak S; Supawat B; Kothan S; Udomtanakunchai C; Tima S; Tungjai M
    Toxicol Rep; 2021; 8():1381-1388. PubMed ID: 34285884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallic acid enhances pirarubicin‑induced anticancer in living K562 and K562/Dox leukemia cancer cells through cellular energetic state impairment and P‑glycoprotein inhibition.
    Aye KT; Wattanapongpitak S; Supawat B; Kothan S; Udomtanakunchai C; Tima S; Pan J; Tungjai M
    Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34476509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Iodinated Radiographic Contrast Media on Multidrug-resistant K562/Dox Cells: Mitochondria Impairment and P-glycoprotein Inhibition.
    Supawat B; Udomtanakunchai C; Kothan S; Tungjai M
    Cell Biochem Biophys; 2019 Jun; 77(2):157-163. PubMed ID: 30924055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pre-low-dose irradiation on anticancer activities of gallic acid in leukemic K562 and K562/Dox cells: cell viability and cellular energetic state studies.
    Aye KT; Wattanapongpitak S; Supawat B; Kothan S; Udomtanakunchai C; Tima S; Tungjai M
    Med Oncol; 2022 Sep; 39(12):229. PubMed ID: 36175689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
    Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
    Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Drug Modulator Diarylheptanoid (
    Viriyaadhammaa N; Duangmano S; Saiai A; Tungjai M; Dejkriengkraikul P; Tima S; Chiampanichayakul S; Krise J; Anuchapreeda S
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012254
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin.
    Xue C; Wang C; Liu Q; Meng Q; Sun H; Huo X; Ma X; Liu Z; Ma X; Peng J; Liu K
    Tumour Biol; 2016 Jul; 37(7):8587-97. PubMed ID: 26733176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does P-glycoprotein play a pivotal role in the drug resistance of an MDR variant, K562/Dox?
    Hu X; Yang H; Pan QR; Zheng S
    Chemotherapy; 1995; 41(4):296-305. PubMed ID: 7555211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Xu HB; Li L; Liu GQ
    Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells.
    Tarasiuk J; Stefańska B; Plodzich I; Tkaczyk-Gobis K; Seksek O; Martelli S; Garnier-Suillerot A; Borowski E
    Br J Pharmacol; 2002 Mar; 135(6):1513-23. PubMed ID: 11906965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
    Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
    Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of cyclosporin A on intracellular accumulation and efflux of drug in K562/DOX cells].
    Meng H; Lin X; Lin M
    Zhonghua Xue Ye Xue Za Zhi; 1997 May; 18(5):254-6. PubMed ID: 15622758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6.
    Zhu HJ; Wang JS; Guo QL; Jiang Y; Liu GQ
    Biol Pharm Bull; 2005 Oct; 28(10):1974-8. PubMed ID: 16204958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
    Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
    Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.
    Yalçintepe L; Halis E; Ulku S
    Oncol Lett; 2016 Mar; 11(3):2290-2296. PubMed ID: 26998164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen.
    Wang HW; Ma KL; Liu H; Zhou JY
    Aging (Albany NY); 2020 Apr; 12(7):6018-6029. PubMed ID: 32259795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Pyrrolinodoxorubicin and its peptide-vectorized form bypass multidrug resistance.
    Castex C; Merida P; Blanc E; Clair P; Rees AR; Temsamani J
    Anticancer Drugs; 2004 Jul; 15(6):609-17. PubMed ID: 15205606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.